Kainate-glutamate interactions in rat cerebellar slices. 1984

J Garthwaite, and G J Gilligan

The effects of L-glutamate on the potency of kainate for stimulating guanosine 3',5'-cyclic monophosphate (cyclic GMP) accumulation and for killing neurones in incubated slices of immature (8-day) and adult rat cerebellum were investigated. L-glutamate did not potentiate the cyclic GMP responses to kainate in either the adult or the immature tissue (in contrast to a recent report), nor did it alter the pharmacological characteristics of this postsynaptic action of kainate in the immature cerebellum. Slices incubated for 2 h in the presence of L-glutamate displayed pronounced glial swelling and neuronal damage. These effects were concentration-dependent and neurones in the immature cerebellum proved to be about 10 times more susceptible than in the adult. None of the neuronal cell types appeared to be selectively vulnerable to the toxicity of glutamate. At the lower concentrations tested (300 microM in the immature tissue, 3 mM in the adult), neurotoxicity was largely restricted to regions near the cut edges of the slices, indicating that very effective mechanisms limit the diffusion of glutamate within the cerebellum. Kainate caused selective necrosis of Purkinje cells and inhibitory interneurones in slices of adult cerebellum at concentrations between 5 and 20 microM; 30 microM kainate, however, also affected granule cells. The neurotoxic potency of kainate towards all neuronal cell types was significantly lower in the immature cerebellum and was not enhanced by including glutamate in the incubation medium. Similarly, glutamate did not potentiate the neurotoxicity of kainate towards Purkinje cells and inhibitory interneurones or or towards granule cells in adult slices. It is concluded that the availability of glutamate is unlikely to be a factor which limits the neurotoxicity of kainate either in the immature or in the adult cerebellum. The increase in the neurotoxic potency of kainate with cerebellar maturation can be ascribed, more readily, to be developmentally-related appearance of kainate receptors.

UI MeSH Term Description Entries
D007608 Kainic Acid (2S-(2 alpha,3 beta,4 beta))-2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid. Ascaricide obtained from the red alga Digenea simplex. It is a potent excitatory amino acid agonist at some types of excitatory amino acid receptors and has been used to discriminate among receptor types. Like many excitatory amino acid agonists it can cause neurotoxicity and has been used experimentally for that purpose. Digenic Acid,Kainate,Acid, Digenic,Acid, Kainic
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002531 Cerebellum The part of brain that lies behind the BRAIN STEM in the posterior base of skull (CRANIAL FOSSA, POSTERIOR). It is also known as the "little brain" with convolutions similar to those of CEREBRAL CORTEX, inner white matter, and deep cerebellar nuclei. Its function is to coordinate voluntary movements, maintain balance, and learn motor skills. Cerebella,Corpus Cerebelli,Parencephalon,Cerebellums,Parencephalons
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D005971 Glutamates Derivatives of GLUTAMIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the 2-aminopentanedioic acid structure. Glutamic Acid Derivatives,Glutamic Acids,Glutaminic Acids
D006152 Cyclic GMP Guanosine cyclic 3',5'-(hydrogen phosphate). A guanine nucleotide containing one phosphate group which is esterified to the sugar moiety in both the 3'- and 5'-positions. It is a cellular regulatory agent and has been described as a second messenger. Its levels increase in response to a variety of hormones, including acetylcholine, insulin, and oxytocin and it has been found to activate specific protein kinases. (From Merck Index, 11th ed) Guanosine Cyclic 3',5'-Monophosphate,Guanosine Cyclic 3,5 Monophosphate,Guanosine Cyclic Monophosphate,Guanosine Cyclic-3',5'-Monophosphate,3',5'-Monophosphate, Guanosine Cyclic,Cyclic 3',5'-Monophosphate, Guanosine,Cyclic Monophosphate, Guanosine,Cyclic-3',5'-Monophosphate, Guanosine,GMP, Cyclic,Guanosine Cyclic 3',5' Monophosphate,Monophosphate, Guanosine Cyclic
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

J Garthwaite, and G J Gilligan
March 1980, European journal of pharmacology,
J Garthwaite, and G J Gilligan
January 1998, Methods in enzymology,
J Garthwaite, and G J Gilligan
February 1979, European journal of pharmacology,
J Garthwaite, and G J Gilligan
June 2002, Neuroscience letters,
J Garthwaite, and G J Gilligan
October 1993, Naunyn-Schmiedeberg's archives of pharmacology,
J Garthwaite, and G J Gilligan
November 2007, Neuroreport,
J Garthwaite, and G J Gilligan
October 1992, European journal of pharmacology,
Copied contents to your clipboard!